127 related articles for article (PubMed ID: 16473667)
1. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction.
Bel Hadj Jrad B; Mahfouth W; Bouaouina N; Gabbouj S; Ahmed SB; Ltaïef M; Jalbout M; Chouchane L
Cancer Lett; 2006 Feb; 233(1):21-7. PubMed ID: 16473667
[TBL] [Abstract][Full Text] [Related]
2. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
3. Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules.
Arasteh JM; Sarvestani EK; Aflaki E; Amirghofran Z
Immunol Invest; 2010; 39(1):27-38. PubMed ID: 20064083
[TBL] [Abstract][Full Text] [Related]
4. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.
Mahfoudh W; Bel Hadj Jrad B; Romdhane A; Chouchane L
Int J Immunogenet; 2007 Jun; 34(3):209-12. PubMed ID: 17504511
[TBL] [Abstract][Full Text] [Related]
5. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
[TBL] [Abstract][Full Text] [Related]
6. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma.
Zhou B; Rao L; Li Y; Gao L; Wang Y; Chen Y; Xue H; Song Y; Peng Y; Liao M; Zhang L
Cancer Lett; 2009 Mar; 275(1):72-6. PubMed ID: 19006646
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
8. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
[TBL] [Abstract][Full Text] [Related]
11. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
12. Fas-1377 A/G polymorphism in lung cancer.
Gormus U; Ergen A; Yaylim-Eraltan I; Yilmaz H; Turna A; Bozkurt N; Isbir T
In Vivo; 2007; 21(4):663-6. PubMed ID: 17708363
[TBL] [Abstract][Full Text] [Related]
13. [Quinone oxidoreductase gene polymorphism and genetic susceptibility to nasopharyngeal carcinoma].
Wu DH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1126-7. PubMed ID: 12480594
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
[TBL] [Abstract][Full Text] [Related]
15. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS
Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Fas gene promoter polymorphism in cervical cancer patients.
Dybikowska A; Sliwinski W; Emerich J; Podhajska AJ
Int J Mol Med; 2004 Sep; 14(3):475-8. PubMed ID: 15289903
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
[TBL] [Abstract][Full Text] [Related]
18. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma.
Yang ZH; Liang WB; Jia J; Wei YS; Zhou B; Zhang L
Acta Oncol; 2008; 47(3):379-84. PubMed ID: 17882560
[TBL] [Abstract][Full Text] [Related]
19. [Association of nasopharyngeal carcinoma risk with cytochrome P450 CYP1A1 gene polymorphisms].
Xu YF; Pan QH; Cui C; Chen LZ; Feng QS; Zeng YX; Jia WH
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):586-90. PubMed ID: 19954069
[TBL] [Abstract][Full Text] [Related]
20. Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction.
Hanasaki H; Takemura Y; Fukuo K; Ohishi M; Onishi M; Yasuda O; Katsuya T; Awata N; Kato N; Ogihara T; Rakugi H
Hypertens Res; 2009 Apr; 32(4):261-4. PubMed ID: 19262492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
